Healthcare / Drug Manufacturers - Specialty & GenericNasdaqGS
$31.78
-1.83 (-5.44%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $274.3M · quality 58.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.0B
P/E
15.4x
↓EV/EBITDA
4.6x
↓ROE
20.8%
↑Gross Margin
59.3%
↑Debt/Equity
2.70
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2013–2025 · 12 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
42.0%
FCF / Net income
5.21x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $780.6M · net income $62.9M · FCF $327.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | $780.6M | $780.6M | $631.4M | $566.8M | $463.9M | $276.9M | $310.0M | $296.7M | $280.4M | $28.5M | $1.7M | — | — | — |
| Net Income | $62.9M | $62.9M | $69.2M | $48.2M | $-25.0M | $71.5M | $26.8M | $-22.7M | $-39.1M | $-74.9M | $-94.2M | $-27.3M | $-17.9M | $-16.2M |
| EBITDA | $401.0M | $401.0M | $341.7M | $308.3M | $173.3M | — | — | $-23.0M | $-19.6M | $-74.9M | $-93.4M | $-26.7M | $-17.5M | — |
| EPS | 1.73 | 1.73 | 1.86 | 1.29 | -0.74 | 1.86 | 0.76 | -0.68 | -1.19 | — | -3.88 | -1.48 | -22.72 | — |
| Gross Margin | 59.3% | 59.3% | 59.8% | 57.5% | 45.2% | 54.4% | 58.0% | 34.7% | 40.9% | — | — | — | — | — |
| Operating Margin | 22.9% | 22.9% | 26.4% | 29.5% | 7.2% | 6.4% | 18.1% | -8.0% | -7.4% | -264.9% | -5498.7% | — | — | — |
| Net Margin | 8.1% | 8.1% | 11.0% | 8.5% | -5.4% | 25.8% | 8.6% | -7.7% | -14.0% | -262.9% | -5504.1% | — | — | — |
| Balance Sheet | ||||||||||||||
| Debt/Equity | 2.70 | 2.70 | 3.75 | 3.45 | 3.64 | — | — | 0.13 | 0.13 | — | 0.03 | — | — | — |
| Current Ratio | 1.71 | 1.71 | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||
| Free Cash Flow | $327.6M | $327.6M | $203.3M | $274.3M | $122.6M | $101.6M | $88.4M | $21.3M | $163.9M | $-68.0M | $-75.5M | $-21.9M | — | — |
| Returns | ||||||||||||||
| ROE | 20.8% | 20.8% | 30.2% | 24.6% | -12.8% | 35.2% | 14.4% | -26.0% | -42.7% | -71.9% | -69.8% | -32.0% | 20.1% | 23.7% |
| Valuation | ||||||||||||||
| P/E | 15.43 | 15.43 | 15.87 | 25.04 | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 4.60 | 4.60 | 5.80 | 5.79 | 8.68 | — | — | — | — | — | — | — | — | — |
| P/B | 4.18 | 4.18 | 5.21 | 6.91 | 4.97 | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||
| Revenue Growth | 23.6% | 23.6% | 11.4% | 22.2% | — | -10.7% | 4.5% | 5.8% | 884.7% | 1564.3% | — | — | — | — |
| EPS Growth | -7.0% | -7.0% | 44.2% | 274.3% | — | 144.7% | 211.8% | 42.9% | — | — | -162.2% | 93.5% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
17.7%
EPS terminal req.
$2.82
Spread vs growth
-24.7%
5Y implied EPS CAGR
14.6%
EPS terminal req.
$3.41
Spread vs growth
-21.5%
10Y implied EPS CAGR
12.3%
EPS terminal req.
$5.50
Spread vs growth
-19.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+9.1%
Start / end P/E
15.7x → 18.4x
EPS bridge
1.86 → 1.73
Residual
-1.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.